IP Library › Granted Patent US 10,752,942
Granted Patent B2
US 10,752,942 · App. 15/947,100 · Granted Aug 25, 2020

Methods and compositions for enrichment of amplification products

Inventors: Li Weng (Fremont, CA); Shengrong Lin (Fremont, CA); Ling Fung Tang (San Francisco, CA)
Assignee: ACCURAGEN HOLDINGS LIMITED
C12Q1/6853C12Q1/68C12Q1/6858G16B25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,752,942
App. No.
15/947,100
Granted
Aug 25, 2020
Kind
B2
Abstract

In some aspects, the present disclosure provides methods for enriching amplicons, or amplification products, comprising a concatemer of at least two or more copies of a target polynucleotide. In some embodiments, a method comprises sequencing the amplicons comprising at least two or more copies of a target polynucleotide. In some embodiments, the target polynucleotides comprise sequences resulting from chromosome rearrangement, including but not limited to point mutations, single nucleotide polymorphisms, insertions, deletions, and translocations including fusion genes. In some aspects, the present disclosure provides compositions and reaction mixtures useful in the described methods.

Claims (63)

1. A method for enriching amplicons comprising a concatemer of more than one copy of a target polynucleotide, the method comprising:

(a) generating a concatemer comprising a single-stranded polynucleotide from a circular target polynucleotide by extension of a first primer, the first primer comprising a first 3′ end that specifically hybridizes to the target polynucleotide via sequence complementarity;

(b) generating a plurality of extension products containing one or more copies of the target polynucleotide by extension of a second primer comprising a second 3′ end that specifically hybridizes to the concatemer via sequence complementarity; and

(c) amplifying the plurality of extension products of step (b) under conditions to generate a plurality of amplicons, wherein amplicons comprising more than one copy of the target polynucleotide are enriched,

wherein the first primer comprises a first 5′ end comprising a first common sequence that does not specifically hybridize to the target polynucleotide via sequence complementarity and the second primer comprises a second 5′ end comprising a second common sequence that does not specifically hybridize to the concatemer via sequence complementarity, and

wherein in the amplifying of step (c) comprises primer extension of a third primer, wherein the third primer comprises a sequence that specifically hybridizes to the first common sequence or the second common sequence via sequence complementarity.

2. The method of claim 1 , wherein the first common sequence and the second common sequence each comprise at least 10 contiguous nucleotides at a 5′ end and are at least 90% identical when optimally aligned.

3. The method of claim 1 , wherein the first common sequence and the second common sequence are identical.

4. The method of claim 1 , wherein the amplifying step of (c) yields a percentage of amplicons more than one copy of the target polynucleotide that is greater than a percentage of amplicons having one copy or fewer of the target polynucleotide.

5. The method of claim 4 , wherein the percentage of amplicons having more than one copy of the target polynucleotide is at least 60%.

6. The method of claim 1 , wherein the extension products form stem loop structures comprising intramolecular hybridization between (i) the first common sequence and a complement of the second common sequence, or (ii) the second common sequence and a complement of the first common sequence.

7. The method of claim 1 , wherein the circular target polynucleotide is a circularized cell free DNA.

8. The method of claim 1 , wherein the circular target polynucleotide is a circularized fragment of genomic DNA.

9. The method of claim 1 , wherein the circular target polynucleotide is single-stranded.

10. The method of claim 1 , further comprising sequencing the plurality of amplicons produced in step (c).

11. The method of claim 1 , wherein a plurality of different target polynucleotides are amplified in the same reaction mixture.

12. The method of claim 1 , wherein step (a) and step (b) comprise an annealing step held at a temperature within ±5° C. of a melting temperature of the first and second primers.

13. The method of claim 1 , wherein step (a) and step (b) comprise an extension step held at a temperature higher than the melting temperature of the first and second primers.

14. The method of claim 1 , wherein step (a) and step (b) comprise a denaturation step held at a temperature equal to or greater than 80° C.

15. The method of claim 1 , wherein step (a) and step (b) comprise no more than 10 cycles of extension of said first and second primer.

16. The method of claim 9 , wherein the sequencing is performed after selectively purifying amplicons comprising more than one copy of the target polynucleotide from amplicons comprising only one copy of the target polynucleotide.

17. A method for enriching amplicons comprising a concatemer of more than one copy of a target polynucleotide, the method comprising:

(a) generating a concatemer comprising a single-stranded polynucleotide from a circular target polynucleotide by extension of a first primer, the first primer comprising a first 3′ end that specifically hybridizes to the target polynucleotide via sequence complementarity;

(b) generating a plurality of extension products containing one or more copies of the target polynucleotide by extension of a second primer comprising a second 3′ end that specifically hybridizes to the concatemer via sequence complementarity; and

(c) amplifying the plurality of extension products of step (b) under conditions to generate a plurality of amplicons, wherein amplicons comprising more than one copy of the target polynucleotide are enriched,

wherein the first primer comprises a first 5′ end comprising a first common sequence that does not specifically hybridize to the target polynucleotide via sequence complementarity and the second primer comprises a second 5′ end comprising a second common sequence that does not specifically hybridize to the concatemer via sequence complementarity, and

wherein the extension products form stem loop structures comprising intramolecular hybridization between (i) the first common sequence and a complement of the second common sequence, or (ii) the second common sequence and a complement of the first common sequence.

18. The method of claim 17 , wherein the first common sequence and the second common sequence each comprise at least 10 contiguous nucleotides at a 5′ end and are at least 90% identical when optimally aligned.

19. The method of claim 17 , wherein the first common sequence and the second common sequence are identical.

20. The method of claim 17 , wherein in the amplifying of step (c) comprises primer extension of a third primer, wherein the third primer comprises a sequence that specifically hybridizes to the first common sequence or the second common sequence via sequence complementarity.

21. The method of claim 17 , wherein the amplifying step of (c) yields a percentage of amplicons more than one copy of the target polynucleotide that is greater than a percentage of amplicons having one copy or fewer of the target polynucleotide.

22. The method of claim 21 , wherein the percentage of amplicons having more than one copy of the target polynucleotide is at least 60%.

23. The method of claim 17 , wherein the circular target polynucleotide is a circularized cell free DNA.

24. The method of claim 17 , wherein the circular target polynucleotide is a circularized fragment of genomic DNA.

25. The method of claim 17 , wherein the circular target polynucleotide is single-stranded.

26. The method of claim 17 , further comprising sequencing the plurality of amplicons produced in step (c).

27. The method of claim 17 , wherein a plurality of different target polynucleotides are amplified in the same reaction mixture.

28. The method of claim 17 , wherein step (a) and step (b) comprise an annealing step held at a temperature within ±5° C. of a melting temperature of the first and second primers.

29. The method of claim 17 , wherein step (a) and step (b) comprise an extension step held at a temperature higher than the melting temperature of the first and second primers.

30. The method of claim 17 , wherein step (a) and step (b) comprise a denaturation step held at a temperature equal to or greater than 80° C.

31. The method of claim 17 , wherein step (a) and step (b) comprise no more than 10 cycles of extension of said first and second primer.

32. The method of claim 25 , wherein the sequencing is performed after selectively purifying amplicons comprising more than one copy of the target polynucleotide from amplicons comprising only one copy of the target polynucleotide.

33. A method for enriching amplicons comprising a concatemer of more than one copy of a target polynucleotide, the method comprising:

(a) generating a concatemer comprising a single-stranded polynucleotide from a circular target polynucleotide by extension of a first primer, the first primer comprising a first 3′ end that specifically hybridizes to the target polynucleotide via sequence complementarity;

(b) generating a plurality of extension products containing one or more copies of the target polynucleotide by extension of a second primer comprising a second 3′ end that specifically hybridizes to the concatemer via sequence complementarity; and

(c) amplifying the plurality of extension products of step (b) under conditions to generate a plurality of amplicons, wherein amplicons comprising more than one copy of the target polynucleotide are enriched,

wherein the circular target polynucleotide is single-stranded, and

wherein the sequencing is performed after selectively purifying amplicons comprising more than one copy of the target polynucleotide from amplicons comprising only one copy of the target polynucleotide.

34. The method of claim 33 , wherein the first primer comprises a first 5′ end comprising a first common sequence that does not specifically hybridize to the target polynucleotide via sequence complementarity and the second primer comprises a second 5′ end comprising a second common sequence that does not specifically hybridize to the concatemer via sequence complementarity.

35. The method of claim 34 , wherein the first common sequence and the second common sequence each comprise at least 10 contiguous nucleotides at a 5′ end and are at least 90% identical when optimally aligned.

36. The method of claim 34 , wherein the first common sequence and the second common sequence are identical.

37. The method of claim 34 , wherein in the amplifying of step (c) comprises primer extension of a third primer, wherein the third primer comprises a sequence that specifically hybridizes to the first common sequence or the second common sequence via sequence complementarity.

38. The method of claim 33 , wherein the amplifying step of (c) yields a percentage of amplicons more than one copy of the target polynucleotide that is greater than a percentage of amplicons having one copy or fewer of the target polynucleotide.

39. The method of claim 38 , wherein the percentage of amplicons having more than one copy of the target polynucleotide is at least 60%.

40. The method of claim 34 , wherein the extension products form stem loop structures comprising intramolecular hybridization between (i) the first common sequence and a complement of the second common sequence, or (ii) the second common sequence and a complement of the first common sequence.

41. The method of claim 33 , wherein the circular target polynucleotide is a circularized cell free DNA.

42. The method of claim 33 , wherein the circular target polynucleotide is a circularized fragment of genomic DNA.

43. The method of claim 33 , further comprising sequencing the plurality of amplicons produced in step (c).

44. The method of claim 33 , wherein a plurality of different target polynucleotides are amplified in the same reaction mixture.

45. The method of claim 33 , wherein step (a) and step (b) comprise an annealing step held at a temperature within ±5° C. of a melting temperature of the first and second primers.

46. The method of claim 33 , wherein step (a) and step (b) comprise an extension step held at a temperature higher than the melting temperature of the first and second primers.

47. The method of claim 33 , wherein step (a) and step (b) comprise a denaturation step held at a temperature equal to or greater than 80° C.

48. The method of claim 33 , wherein step (a) and step (b) comprise no more than 10 cycles of extension of said first and second primer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2025
From: ACCURAGEN HOLDINGS LIMITED
To: ACCUSCAN SCIENCES INC.
Reel/Frame 074035/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2018
From: WENG, LI; LIN, SHENGRONG; TANG, LING FUNG
To: ACCURAGEN HOLDINGS LIMITED
Reel/Frame 045859/0493 →
Continuity (3)
Continuation PCTUS2016056126 · Oct 7, 2016
Provisional Application 62239690 · Oct 9, 2015
Related Publication 20180298434A1 · Oct 18, 2018
Cited By (2)
US 12,234,512 US 12,247,252